Funds advised by HIG European Capital Partners LLP and its debt affiliate, Bayside Capital, have acquired Bezier, the UK’s largest provider of integrated point of sale marketing services.   The transaction was facilitated by the acquisition of Bezier’s senior debt with a face value of over GBP70 million, and will

Vector Capital is to acquire Motorola Solutions’ Point-to-Point (PTP or Orthogon) and Point-to-Multipoint (PMP or Canopy) Wireless Broadband Networks businesses for an undisclosed amount. The transaction is expected to be completed as early as the end of September and is subject to customary closing conditions. The Motorola PTP and PMP

Signal Peak Ventures, a newly-established venture fund manager, is forming a new fund focused on early-stage investment opportunities in the Intermountain region. The fund is backed by a syndicate of limited partners led by StepStone Group. Simultaneously with its formation, Signal Peak acquired substantially all of the venture capital assets

The MENA Private Equity Association has launched a free directory aimed at entrepreneurs and businesses looking for venture capital funding. Over 50 VC firms, angel investors, business incubators and technology parks are represented in the online directory, which will be continuously updated as the venture capital ecosystem expands. 

 MENA’s

European private equity firm, Cinven, has completed the sale of Phadia Group, the leading in-vitro allergy diagnostics company based in Uppsala (Sweden), to Thermo Fisher Scientific Inc. Cinven announced the agreement to sell Phadia Group in May 2011 for an enterprise value of EUR2.47 billion. Cinven’s Healthcare team led the

Olswang has advised the shareholders of Pathway Care Group Limited, including funds managed by ISIS Equity Partners (ISIS), on the sale to Fostering Solutions Limited. After a six year investment in the organisation, which saw significant expansion across the UK and involved increasing the foster carer base from 210 to

George Little Management (GLM) and Providence Equity Partners have signed a definitive merger agreement under which affiliates of Providence will acquire GLM from Daily Mail and General Trust plc (LSE: DMGT.L) for approximately USD173 million in cash. GLM creates face-to-face and online buying, selling and networking platforms for designers, product

Spinifex Pharmaceuticals, an Australian pain drug development company, has secured a further AUD6.25 million of venture capital investment from GBS Venture Partners Limited, Brandon Capital Partners Pty Limited, Uniseed Management Pty Limited and UniQuest Pty Limited to fund the development of its pain management drug, EMA401. This expanded Series B